Imagin Medical

Imagin Medical's mission is to improve outcomes and quality of life for patients with prostate and bladder cancer through innovative, precision-focused medical devices. The company's strategy is built on a dual-product pipeline addressing both therapeutic intervention and diagnostic accuracy, managed by a team with proven success in medical device entrepreneurship and commercialization. Key achievements include the development of patented technology platforms with promising initial clinical data, positioning the company for regulatory submissions and subsequent market entry in large, underserved oncology markets.

Two core platforms: 1) The enCAGE Coil, a precision ablation system using a patented 'Faraday Effect' to contain electromagnetic energy for targeted prostate cancer treatment. 2) The i/Blue Imaging System, incorporating advanced optics and light sensors to enhance visual detection of bladder cancer during cystoscopy.

In prostate focal therapy, enCAGE competes with HIFU, cryoablation, and laser systems, differentiating via its claimed precision containment of energy. In bladder cancer imaging, i/Blue would compete against photodynamic diagnosis (blue-light cystoscopy with an agent) and other advanced imaging modalities, with a potential advantage of not requiring an instilled photosensitizer.